Last updated: August 28, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
bioptron light therapy
Clinical Study ID
NCT05964673
P.T.REC/012/004549
Ages 50-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All participants are postmenopausal women.
- Their age above 50 years old
- All participants aren't on any systematic therapy.
Exclusion
Exclusion Criteria:
- • Injuries and previous surgical treatment of eyes
- All patients with diagnosis of chronic blepharitis, meibominitis or any other eyeinfections
- Participants with autoimmune diseases such as Sjögren's syndrome (SS), rheumatoidarthritis (RA) and systemic lupus erythematosus (SLE)
- Diabetic participants will be excluded.
- Smokers will be excluded from the study.
- The use of Hormone Replacement Therapy
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: bioptron light therapy
Phase:
Study Start date:
May 09, 2023
Estimated Completion Date:
November 08, 2023
Study Description
Connect with a study center
Cairo University
Cairo,, 11432
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.